Assessment of Nevirapine Bioavailability From Targeted Sites in the Human Gastrointestinal Tract
- 1 December 2009
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 49 (12), 1417-1425
- https://doi.org/10.1177/0091270009344856
Abstract
This study investigated absorption of nevirapine (NVP) from targeted sites of the gastrointestinal tract using remotely activated capsules and gamma scintigraphy. A total of 24 participants were randomized to receive 50 mg NVP orally as a suspension or via remotely activated capsules for release into the ascending colon. The 24 participants were then rerandomized into parallel groups of n = 8 for drug release into the ileum, jejunum, or descending colon. The mean gastric emptying time of capsules ranged from 0.88 to 3.35 hours. The small intestinal and colon transit time ranged from 4.08 to 7.76 hours and 17.6 to 21.2 hours, respectively, and capsule recovery time ranged from 27.6 to 34.4 hours. The relative bioavailability ratio of NVP in the jejunum was 1.06 (90% confidence interval [CI]: 1.00–1.12) compared to suspension. In the ileum, ascending colon, and descending colon, bioavailability decreased to 0.89 (0.80–0.99), 0.82 (0.71–0.95), and 0.58 (0.22–1.53), respectively. The absorption rate decreased by ∼10‐fold from the jejunum (3.83 h−1) to the descending colon (0.338 h−1), and tmax increased from 2.42 hours (jejunum) to 16.3 hours (descending colon). Overall, NVP is absorbed from all 4 sites of the gastrointestinal tract, and the rate of absorption decreased from the jejunum to the descending colon. Relative bioavailability of NVP was in the order of jejunum > ileum > ascending colon > descending colon.Keywords
This publication has 21 references indexed in Scilit:
- Quantitation of five nevirapine oxidative metabolites in human plasma using liquid chromatography–tandem mass spectrometryJournal of Chromatography B, 2007
- Pharmacokinetics of Nevirapine: Once-Daily Versus Twice-Daily Dosing in the 2NN StudyHIV Research & Clinical Practice, 2005
- Bioequivalence Testing for Locally Acting Gastrointestinal Products: What Role for Gamma Scintigraphy?The Journal of Clinical Pharmacology, 2002
- The role of γ-scintigraphy in oral drug deliveryAdvanced Drug Delivery Reviews, 2001
- The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic responseAIDS, 1999
- Ciprofloxacin absorption in different regions of the human gastrointestinal tract. Investigations with the hf‐capsule.British Journal of Clinical Pharmacology, 1990
- The influence of food on the gastric emptying of multiparticulate dosage formsInternational Journal of Pharmaceutics, 1987
- Measurement of theophylline absorption from different regions of the gastro-intestinal tract using a remote controlled durg delivery deviceEuropean Journal of Clinical Pharmacology, 1986
- Drug delivery to the proximal colonJournal of Pharmacy and Pharmacology, 1985
- Kinetic Analysis of Blood Levels and Urinary Excretion in the Absorptive Phase after Single Doses of DrugJournal of Pharmaceutical Sciences, 1964